Thank you for your
interest in Colorado Allergy & Asthma Centers, P.C.
|
Our
Mission
We are dedicated to the delivery of personalized,
quality care by putting the patient first. We accomplish this
by managing health, treating disease, and fostering education
through research and community involvement. |
| .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . |
 |
Clinical Research
Colorado Allergy And Asthma Center, P.C.,
have participated in clinical research evaluating new treatments
of asthma and allergies for adults, adolescents, and children
for over 30 years. Most of our participating subjects are patients
from our practice. Please see the Clinical
Research page for more information. |
| .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . |
|
| Current News
|
|
| "Early
Communications" From FDA re: Singulair By Leon Greos, M.D. |
The
FDA has released an “Early Communication” about an ongoing
safety review of Singulair (montelukast), a medicine
in a class of drugs known as leukotriene receptor antagonists
and commonly used in the treatment of asthma and allergies...For
complete article click
here.
|
|
| .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . |
| 2008
Spring Newsletter |
|
CAAC
distributes their newsletters in the Spring and Fall.
Our Spring Newsletter includes articles such as"Allergy
Immunotherapy (allergy shots): The Ultimate Treatment
for Allergies" by Nan Laoprasert, M.D., "Oral
Desenitzation to Foods " by John M. James, M.D.,
and "In Step with Research - Volunteer Opportunitites".
|
|
| .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . |
| Founder's
Award Scholarship Fund 2008 Deadline is Approaching!! |
|
Deadline
is June 1, 2008
The eligibility requirements
include graduating high school seniors and college undergraduates
or graduate students who are in good academic standing
and have been accepted by or are currently enrolled
in an accredited U.S. college. Applicants must have
been a patient of CAAC, P.C. for one year minimum, a
patient within the last year and a U.S. Citizen.
For more information please click
here.
To learn more about last years Scholarship recipient
click here.
|
|
| .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . |
| Congratulations
to Dr. Mark Ebadi |
|
Congratulations,
Dr. Mark Ebadi in being named one of the Top Doctors
of 2007 in Allergy & Immunology by 5280 Magazine.
Dr. Mark A. Ebadi was also one of the Top Doctors of
2006. 5280 has provided this list of Top Docs in the
Denver area for 14 years. This recognition was received
by votes from the Denver Metro area physicians.
For the article on Dr. Mark Ebadi, click
here.
|
|
|
